NEW YORK--(BUSINESS WIRE)--Acquisition of Myst Therapeutics adds proprietary tumor infiltrating lymphocyte (“TIL”) technology and programs to Turnstone’s growing portfolio
Source Read More
Mayo Clinic Laboratories and American Hospital Dubai Announce Strategic Partnership
American Hospital Dubai (Photo: AETOSWire)
January 17, 2021 12:25 PM Eastern Standard Time
DUBAI, United Arab...
City of Hope Scientists Have Developed a Precision Medicine Tool That Predicts If Chemotherapy Will Produce Debilitating Side Effects in Older Adults
This easy-to-use risk...
Veristat Supported Marketing Applications for 10% of All FDA Novel Drug Approvals in 2020
Strengthening its Track Record of Successful Client Regulatory Approval Outcomes
January 14,...
Gilead and Vir Biotechnology Establish Clinical Collaboration to Explore Combination Strategies for Functional Cure for Chronic Hepatitis B Virus
-- First Phase 2 Clinical Trial...
AvantGen Announces Licensing of Its Anti-SARS-CoV-2 Antibodies to IGM Biosciences for COVID-19 Therapy Development
January 11, 2021 06:59 PM Eastern Standard Time
SAN DIEGO--(BUSINESS WIRE)--AvantGen, Inc.,...
